|
|
 Previous Article | Table of Contents | Next Article 
Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with
long-term proliferative ability in vitro and in vivo
A Blair, DE Hogge, LE Ailles, PM Lansdorp and HJ Sutherland
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver Hospital
and Health Sciences Centre, Canada.
Acute myeloid leukaemia (AML) is thought to be maintained by a small
population of leukemic progenitor cells. To define the phenotype of such
cells with long-term proliferative capacity in vitro and in vivo, we have
used the production of leukemic clonogenic cells (CFU) after 2 to 8 weeks
in suspension culture as a measure of these cells in vitro and compared
their phenotype with that of cells capable of engrafting nonobese diabetic
severe combined immune deficient (NOD/SCID) mice. Leukemic blast peripheral
blood cells were evaluated for expression of CD34 and Thy-1 (CD90)
antigens. The majority of AML blast cells at diagnosis lacked expression of
Thy-1. Most primary CFU-blast and the CFU detected at up to 8 weeks from
suspension cultures were CD34+/Thy-1- . AML cells that were capable of
engrafting NOD/SCID mice were also found to have the CD34+/Thy-1-
phenotype. However, significant engraftment was achieved using both
CD34+/Thy-1- and CD34- subfractions from one AML M5 patient. These results
suggest that while heterogeneity exists between individual patients, the
leukemic progenitor cells that are capable of maintaining the disease in
vitro and in vivo differ from normal hematopoietic progenitor cells in
their lack of expression of Thy-1.
Volume 89,
Issue 9,
pp. 3104-3112,
05/01/1997
Copyright © 1997 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. V. Cox, P. Diamanti, R. S. Evely, P. R. Kearns, and A. Blair
Expression of CD133 on leukemia-initiating cells in childhood ALL
Blood,
April 2, 2009;
113(14):
3287 - 3296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Majeti, M. W. Becker, Q. Tian, T.-L. M. Lee, X. Yan, R. Liu, J.-H. Chiang, L. Hood, M. F. Clarke, and I. L. Weissman
Dysregulated gene expression networks in human acute myelogenous leukemia stem cells
PNAS,
March 3, 2009;
106(9):
3396 - 3401.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.P. Chao, J. Seita, and I.L. Weissman
Establishment of a Normal Hematopoietic and Leukemia Stem Cell Hierarchy
Cold Spring Harb Symp Quant Biol,
November 6, 2008;
(2008)
sqb.2008.73.031v1.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. C. Taussig, F. Miraki-Moud, F. Anjos-Afonso, D. J. Pearce, K. Allen, C. Ridler, D. Lillington, H. Oakervee, J. Cavenagh, S. G. Agrawal, et al.
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
Blood,
August 1, 2008;
112(3):
568 - 575.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E.P. Prince and L. E. Ailles
Cancer Stem Cells in Head and Neck Squamous Cell Cancer
J. Clin. Oncol.,
June 10, 2008;
26(17):
2871 - 2875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Hosen, C. Y. Park, N. Tatsumi, Y. Oji, H. Sugiyama, M. Gramatzki, A. M. Krensky, and I. L. Weissman
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
PNAS,
June 26, 2007;
104(26):
11008 - 11013.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Giangreco, K. R. Groot, and S. M. Janes
Lung Cancer and Lung Stem Cells: Strange Bedfellows?
Am. J. Respir. Crit. Care Med.,
March 15, 2007;
175(6):
547 - 553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Prince, R. Sivanandan, A. Kaczorowski, G. T. Wolf, M. J. Kaplan, P. Dalerba, I. L. Weissman, M. F. Clarke, and L. E. Ailles
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
PNAS,
January 16, 2007;
104(3):
973 - 978.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. V. Cox, H. M. Martin, P. R. Kearns, P. Virgo, R. S. Evely, and A. Blair
Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia
Blood,
January 15, 2007;
109(2):
674 - 682.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Yalcintepe, A. E. Frankel, and D. E. Hogge
Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice
Blood,
November 15, 2006;
108(10):
3530 - 3537.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Pearce, D. Taussig, K. Zibara, L.-L. Smith, C. M. Ridler, C. Preudhomme, B. D. Young, A. Z. Rohatiner, T. A. Lister, and D. Bonnet
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML
Blood,
February 1, 2006;
107(3):
1166 - 1173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Ravandi and Z. Estrov
Eradication of Leukemia Stem Cells as a New Goal of Therapy in Leukemia
Clin. Cancer Res.,
January 15, 2006;
12(2):
340 - 344.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Guzman, R. M. Rossi, L. Karnischky, X. Li, D. R. Peterson, D. S. Howard, and C. T. Jordan
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
Blood,
June 1, 2005;
105(11):
4163 - 4169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Walter, J. S. Park, S. K. M. Lau, X. Li, A. A. Lane, R. Nagarajan, W. D. Shannon, and T. J. Ley
Expression Profiling of Murine Acute Promyelocytic Leukemia Cells Reveals Multiple Model-Dependent Progression Signatures
Mol. Cell. Biol.,
December 15, 2004;
24(24):
10882 - 10893.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. V. Cox, R. S. Evely, A. Oakhill, D. H. Pamphilon, N. J. Goulden, and A. Blair
Characterization of acute lymphoblastic leukemia progenitor cells
Blood,
November 1, 2004;
104(9):
2919 - 2925.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Guan, B. Gerhard, and D. E. Hogge
Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML)
Blood,
April 15, 2003;
101(8):
3142 - 3149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Guzman, C. F. Swiderski, D. S. Howard, B. A. Grimes, R. M. Rossi, S. J. Szilvassy, and C. T. Jordan
Preferential induction of apoptosis for primary human leukemic stem cells
PNAS,
December 10, 2002;
99(25):
16220 - 16225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Testa, R. Riccioni, S. Militi, E. Coccia, E. Stellacci, P. Samoggia, R. Latagliata, G. Mariani, A. Rossini, A. Battistini, et al.
Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis
Blood,
September 26, 2002;
100(8):
2980 - 2988.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Feuring-Buske, A. E. Frankel, R. L. Alexander, B. Gerhard, and D. E. Hogge
A Diphtheria Toxin-Interleukin 3 Fusion Protein Is Cytotoxic to Primitive Acute Myeloid Leukemia Progenitors But Spares Normal Progenitors
Cancer Res.,
March 1, 2002;
62(6):
1730 - 1736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Guzman, S. J. Neering, D. Upchurch, B. Grimes, D. S. Howard, D. A. Rizzieri, S. M. Luger, and C. T. Jordan
Nuclear factor-{kappa}B is constitutively activated in primitive human acute myelogenous leukemia cells
Blood,
October 15, 2001;
98(8):
2301 - 2307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. G. Wulf, R.-Y. Wang, I. Kuehnle, D. Weidner, F. Marini, M. K. Brenner, M. Andreeff, and M. A. Goodell
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
Blood,
August 15, 2001;
98(4):
1166 - 1173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Feuring-Buske and D. E. Hogge
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38{-} progenitor cells from patients with acute myeloid leukemia
Blood,
June 15, 2001;
97(12):
3882 - 3889.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. R. Appelbaum, J. M. Rowe, J. Radich, and J. E. Dick
Acute Myeloid Leukemia
Hematology,
January 1, 2001;
2001(1):
62 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Glimm, I.-H. Oh, and C. J. Eaves
Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter G0
Blood,
December 15, 2000;
96(13):
4185 - 4193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Ailles, B. Gerhard, H. Kawagoe, and D. E. Hogge
Growth Characteristics of Acute Myelogenous Leukemia Progenitors That Initiate Malignant Hematopoiesis in Nonobese Diabetic/Severe Combined Immunodeficient Mice
Blood,
September 1, 1999;
94(5):
1761 - 1772.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Blair, D.E. Hogge, and H.J. Sutherland
Most Acute Myeloid Leukemia Progenitor Cells With Long-Term Proliferative Ability In Vitro and In Vivo Have the Phenotype CD34+/CD71-/HLA-DR-
Blood,
December 1, 1998;
92(11):
4325 - 4335.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
